Galapagos NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
23 feb 2015 - 07:41
Statutaire naam
Galapagos NV
Titel
Galapagos reports that the last patient in DARWIN 1 has completed 12 weeks of treatment
Bericht
Last of 599 enrolled rheumatoid arthritis patients has completed the 12 week visit with filgotinib (GLPG0634) or placebo
Triggers start of final 12 week data collection, followed by completion of data verification and data analysis
Topline 12 week results expected to be released by mid-April 2015
Datum laatste update: 28 juli 2024